Ultragenyx Pharmaceutical
RARE
RARE
100 hedge funds and large institutions have $1.23B invested in Ultragenyx Pharmaceutical in 2014 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
18% less capital invested
Capital invested by funds: $1.5B → $1.23B (-$271M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
100
Holding in Top 10
–
Calls
$342K
Puts
$399K
Top Buyers
| 1 | +$17.6M | |
| 2 | +$13.3M | |
| 3 | +$12.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.58M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.21M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$20.2M | |
| 3 | -$6.59M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$3.79M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.46M |